Medical Marketing, Sjögren’s Disease - Opinion Leader Engagement & Peer-to-Peer, Senior Manager
Amgen
Summary
Sjögren’s disease is a debilitating autoimmune disease with significant unmet medical need and no approved disease-modifying therapies. Dazodalibep is an investigational medicine currently in Phase 3 clinical development for the treatment of Sjögren’s disease. As a potential first-in-class treatment in a disease area with significant unmet need, the U.S. launch will require both compelling brand strategy and innovative approaches to educate, engage, and activate HCPs.
Job description
In this role, the Medical Marketing – Sjögren’s Disease, Senior Manager will lead the U.S. opinion leader (OL) engagement and Peer-to-Peer (P2P) strategy, Sjögren’s Disease Speaker Bureau, and marketing-led HCP education. Reporting to the Director of Medical Marketing, this individual will translate brand priorities into an integrated external engagement model that strengthens strategic relationships, customer confidence, brand differentiation, and high-quality field execution.
Key Responsibilities
- Set and evolve the U.S. opinion leader (OL) engagement and peer-to-peer (P2P) strategy for Sjögren’s Disease, translating brand priorities, customer needs, and the evolving treatment landscape into clear engagement priorities for launch and beyond
- Map and segment established and emerging OLs, partnering with Medical Affairs, Field Medical, TLLs, and HCP Marketing to build a coordinated, insight-led engagement plan
- Build trusted relationships across the OL community to deepen customer understanding, surface emerging opportunities, and inform brand and launch decisions
- Lead the Sjögren’s Disease Speaker Bureau, including speaker recruitment, onboarding, segmentation, activation, and ongoing optimization
- Manage marketing-led HCP education programs, including speaker programs, Peer Discussion Groups, ITUs, and other approved educational initiatives
- Lead speaker training and development, including curriculum design, content preparation, faculty training, and ongoing capability building
- Shape marketing-led OL engagement at congresses, including symposia, product theaters, ITUs, faculty activities, and other approved programs
- Coordinate priority engagements with TLLs and cross-functional partners ensuring appropriate follow-up and integration with broader congress plans
- Partner with the TLL Lead and Commercial Training to shape the TLL onboarding and training curriculum, building the knowledge, skills, and capabilities needed for effective customer engagement and field execution
- Oversee the development and lifecycle of P2P content and resources, guiding agency partners through development, review and approval, rollout, and updates
- Use program data, customer feedback, field insights, and competitive intelligence to assess performance, identify opportunities, and improve the P2P and OL engagement approach
- Synthesize OL, customer, and program insights into actionable input for brand and tactical planning; communicate key learnings, opportunities, and risks to cross-functional stakeholders
- Manage budgets, agencies, and external partners with strong financial stewardship, sound prioritization, compliance, and attention to quality
- Foster a culture of scientific curiosity, customer centricity, ownership, collaboration, and innovation, modeling Amgen Values and maintaining high standards across the Sjögren’s disease brand team and cross-functional partnerships
Requirements
- Doctorate degree and 2 years of marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization; OR Master's degree and 4 years of marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization; OR Bachelor's degree and 6 years of marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization; OR Associate's degree and 10 years of marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization; OR High school diploma / GED and 12 years of marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization
- Strong Medical Marketing, OL engagement, and P2P expertise, including OL mapping and engagement planning, Speaker Bureau operations, speaker training, marketing-led HCP education, promotional content development, and multichannel education
- Experience leading P2P and marketing-led OL/HCP engagements end-to-end, including congress-based programs, speaker strategy, faculty management, program design, agency/vendor management, budget oversight, performance optimization, and promotional review through systems such as Veeva PromoMats
- Rheumatology experience preferred; rare disease and launch or in-line brand experience preferred
- Strong strategic thinking, analytical rigor, project management, and communication skills, with the ability to synthesize complex information, lead through influence, and deliver across multiple cross-functional workstreams
- Excellent communication skills and self-awareness of leadership style, with the ability to clearly articulate strategy and influence stakeholders
- Ability to build positive relationships and collaborate effectively in a matrix organization across cross-functional and external partners
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Retirement and Savings Plan
- Life Insurance
- Disability Insurance
- Flexible Spending Accounts
- Annual Bonus Program
- Stock-based Long-term Incentives
- Paid Time Off
- Flexible Work Models
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.